Maravai LifeSciences Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Welcome to our next fireside chat here with Maravai LifeSciences, excited to have Trey Martin, CEO; and Kevin Herde, CFO with us today. I'm John Sourbeer, one of the UBS life sciences analyst. Joining me today is Liza Garcia, my co-coverage.
Questions & Answers
So Trey, I think this might be the first fireside chat you've done since taking over officially as the CEO role. Congrats there. Maybe just high level here, while the first time in the fireside chat. Can you provide some color on your vision for Maravai's portfolio of assets. Do you see any change in strategy? How are you viewing your strategy here now taking over the CEO role officially?
Yes. So I would say part of the situational assessment is what do you come into. And Maravai has certainly had one of the more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |